Atherosclerosis of the circle of Willis (moderate + severe vs. none + mild)
|
Amygdala
|
0.96 (0.63–1.47)
|
0.87
|
0.90 (0.58–1.39)
|
0.63
|
Hippocampus
|
1.07 (0.74–1.55)
|
0.70
|
0.98 (0.67–1.43)
|
0.93
|
EC/inferior TCTX
|
1.16 (0.77–1.75)
|
0.48
|
1.07 (0.70–1.62)
|
0.77
|
Frontal neocortex
|
1.03 (0.47–2.27)
|
0.93
|
1.00 (0.45–2.21)
|
0.99
|
Cerebral amyloid angiopathy (moderate + severe vs. none + mild)
|
Amygdala
|
0.82 (0.52–1.28)
|
0.38
|
0.66 (0.41–1.04)
|
0.077
|
Hippocampus
|
0.89 (0.59–1.32)
|
0.57
|
0.71 (0.47–1.07)
|
0.10
|
EC/inferior TCTX
|
0.99 (0.64–1.52)
|
0.97
|
0.79 (0.50–1.22)
|
0.29
|
Frontal neocortex
|
1.16 (0.49–2.60)
|
0.73
|
1.11 (0.46–2.56)
|
0.81
|
Infarct and lacunes (yes vs. no)
|
Amygdala
|
0.77 (0.43–1.32)
|
0.35
|
0.84 (0.47–1.45)
|
0.54
|
Hippocampus
|
0.76 (0.45–1.23)
|
0.28
|
0.81 (0.48–1.33)
|
0.42
|
EC/inferior TCTX
|
0.79 (0.45–1.32)
|
0.38
|
0.87 (0.49–1.48)
|
0.61
|
Frontal neocortex
|
1.64 (0.63–3.82)
|
0.27
|
1.66 (0.63–3.89)
|
0.26
|
Microinfarcts (yes vs. no)
|
Amygdala
|
1.15 (0.73–1.79)
|
0.55
|
1.08 (0.68–1.70)
|
0.74
|
Hippocampus
|
1.14 (0.76–1.70)
|
0.51
|
1.14 (0.75–1.70)
|
0.54
|
EC/inferior TCTX
|
1.25 (0.80–1.94)
|
0.31
|
1.21 (0.77–1.88)
|
0.41
|
Frontal neocortex
|
1.76 (0.78–3.84)
|
0.16
|
1.77 (0.78–3.86)
|
0.16
|
Hemorrhages and microbleeds (yes vs. no)
|
Amygdala
|
0.65 (0.26–1.44)
|
0.32
|
0.65 (0.25–1.47)
|
0.33
|
Hippocampus
|
0.71 (0.30–1.50)
|
0.40
|
0.69 (0.29–1.46)
|
0.36
|
EC/inferior TCTX
|
0.57 (0.21–1.29)
|
0.21
|
0.55 (0.20–1.26)
|
0.19
|
Frontal neocortex
|
0.45 (0.02–2.34)
|
0.45
|
0.44 (0.02–2.32)
|
0.44
|
Arteriolosclerosis (moderate + severe vs. none + mild)
|
Amygdala
|
1.56 (1.03–2.37)
|
0.038
|
1.38 (0.90–2.13)
|
0.14
|
Hippocampus
|
1.31 (0.92–1.89)
|
0.14
|
1.16 (0.80–1.69)
|
0.42
|
EC/inferior TCTX
|
1.77 (1.17–2.72)
|
0.0078
|
1.61 (1.05–2.49)
|
0.029
|
Frontal neocortex
|
0.97 (0.45–2.13)
|
0.95
|
0.93 (0.43–2.06)
|
0.86
|